Genital Wart Recurrence Among Men Residing in Brazil, Mexico, and the United States
- PMID: 30388232
- PMCID: PMC6376908
- DOI: 10.1093/infdis/jiy533
Genital Wart Recurrence Among Men Residing in Brazil, Mexico, and the United States
Abstract
Background: Genital wart (GW) incidence is high among men. The percentage and rate at which subsequent GW events occur are understudied. The purpose of this study was to describe the rate of subsequent GWs, associated human papillomavirus (HPV) types, and time to subsequent GW event among unvaccinated men.
Methods: The study was nested within a multinational prospective HPV natural history study of men aged 18-70 years in the United States, Mexico, and Brazil, examined every 6 months for a median follow-up of 50.4 months. Subsequent GW events were defined as GWs detected after ≥16 weeks of the prior event.
Results: Forty-four percent of men experienced ≥1 GW following the initial episode. Men with ≥2 subsequent events were at highest risk of continued GW experiences, with as high as 10 postinitial GW events. The incidence rate of each subsequent GW increased with increasing events (incidence of first subsequent event was 13.1 vs 36.6/1000 person-months for the fourth event). The proportion of GWs among HPV-6 and/or -11-positive patients remained constant across events. Approximately 63%-69% were positive for ≥1 of the 9-valent HPV vaccine types.
Conclusions: These data highlight the high burden of GWs among men across the lifespan and the need for vaccination to prevent multiple GW episodes.
Keywords: HPV; genital warts; vaccination.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Figures
Comment in
-
A Very Common Intimate Concern: "Will My Genital Warts Ever Stop Recurring?".J Infect Dis. 2019 Feb 15;219(5):682-684. doi: 10.1093/infdis/jiy610. J Infect Dis. 2019. PMID: 30346559 No abstract available.
References
-
- de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13:607–15. - PubMed
-
- World Health Organization. Global strategy for the prevention and control of sexually transmitted infections (2006–2015). Geneva, Switzerland: WHO, 2007.
-
- Forman D, de Martel C, Lacey CJ, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012; 30(Suppl 5):F12–23. - PubMed
-
- Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006; 24(Suppl 3):S3/35–41. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
